Alpha Tau Medical Ltd. (DRTSW) SEC Filings — 2025

Filings

• Alpha Tau Medical to Present at J.P. Morgan Healthcare Conference — 6-K · Dec 18, 2025
• Alpha Tau Medical Ltd. 6-K Filing — 6-K · Dec 9, 2025
• Alpha Tau Medical to Present Pancreatic Cancer Data at ASCO GI — 6-K · Dec 4, 2025
• Alpha Tau Medical Gets FDA Green Light for Prostate Cancer Trial — 6-K · Dec 2, 2025
• Alpha Tau Medical Ltd. 6-K Filing — 6-K · Nov 20, 2025
• Alpha Tau Medical Secures NH Radioactive Material License — 6-K · Oct 21, 2025
• Alpha Tau Medical treats first patient in US pancreatic cancer trial — 6-K · Sep 2, 2025
• Alpha Tau Medical to Attend 5 Investor Conferences in September — 6-K · Aug 27, 2025
• Alpha Tau Medical Ltd. Files Interim Financials — 6-K · Aug 11, 2025
• Alpha Tau Medical Ltd. Elects Directors at Annual Meeting — 6-K · Jun 17, 2025
• Alpha Tau Medical to Present at Jefferies Healthcare Conference — 6-K · May 28, 2025
• Alpha Tau Medical Reports Q1 2025 Results — 6-K · May 19, 2025
• Alpha Tau Medical Sets Annual Shareholder Meeting for June 17 — 6-K · May 13, 2025
• Alpha Tau Medical Appoints Nadav Kidron to Board — 6-K · May 12, 2025
• Alpha Tau Medical to Attend May Investor Conferences — 6-K · May 6, 2025
• Alpha Tau Medical Raises $28.2M in Direct Offering — 6-K · Apr 28, 2025
• Alpha Tau Medical Gets FDA Green Light for Glioblastoma Trial — 6-K · Apr 2, 2025
• Alpha Tau Medical Ltd. Files 2024 Annual Report — 20-F · Mar 12, 2025
• Alpha Tau Medical to Attend March Investor Conferences — 6-K · Feb 27, 2025
• Alpha Tau Medical Achieves MDSAP Certification — 6-K · Feb 24, 2025
• Alpha Tau Medical Gets FDA Approval for Pancreatic Cancer Trial Expansion — 6-K · Feb 3, 2025
• Alpha Tau Medical Shares Clinical Trial Data Update — 6-K · Jan 27, 2025